Ann: Quarterly Activities Report and Appendix 4C, page-184

They are not doing trial, they are piloting ResAppDx in the real world situation on patient which is totally different and thought you would have known given you have invested in RAP for so long and there is no issue with the Android version, they need QA on each version of Android phone which they've successfully done for Samsung, similarly successfully done to the different version of iPhone.

Fundamentally nothing changed from the quarterly as these important news are still on schedule to be completed in 2-3 months time so the market are still waiting for them. From the top 20 report, Avanti didn't sell their shares at 10-14c since they received the 9M shares at 10c so you would think they would have done by now which could explain the amount of shares being oversold and scooped up by other buyers on Friday.......